Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Ifosfamide for Injection

Effects and efficacy:
Applicable to testicular cancer, ovarian cancer, breast cancer, sarcoma, malignant lymphoma and lung cancer, etc.
Usage and dosage:
This product is administered by intravenous drip. This product is dissolved in sterile water for injection and then further diluted with 500-1000ml of 0.9% sodium chloride injection and then slowly dripped intravenously for at least 30 minutes. Monotherapy: intravenous injection of 1.2-2.5g/m2 per body surface area, 5 consecutive days as a course of treatment. Combination therapy: intravenous injection of 1.2-2.0g/m2 per body surface area, 5 consecutive days as a course of treatment. The next course of treatment should be 3-4 weeks apart or after blood toxicity is recovered (platelets 100000/μl, white blood cells 4000/μl). The maximum dose is 18g/m2. To prevent bladder toxicity, a large amount of water should be consumed, and 2L of fluid should be infused orally or intravenously every day. At the same time, protective agents such as mesna should be used to prevent hemorrhagic cystitis. Mesna dissolved in saline is administered intravenously at the same time and 4 and 8 hours after administration. The usual dosage of mesna is 20% of the total daily amount of ifosfamide. The same drug produced by different manufacturers may have inconsistent instructions. If the instructions are inconsistent before taking the drug, please consult a doctor or pharmacist in time.
Drug contraindications:
Allergic to this product is prohibited during pregnancy and lactation. Use with caution in patients with liver and kidney dysfunction
Related dosage forms:
Injection

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.